Chronic pain is complex and difficult to treat. Prescribing opioid pain medications has become controversial but may help ...

Documents show that the company that facilitated purchase of children’s pain medication and a pair of proposed surgical facilities share a common owner ...

With the goal of informing clinician practice, a new study explores the harms and benefits of continuing and of discontinuing the long-term prescription of opioid medicines to adults with chronic pain ...

Current political and economic issues succinctly explained. Sign up for a summary of global news developments with CFR analysis delivered to your inbox every weekday morning. Subscribe to the ...

The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...

A pee color chart can ... you ate or a medication you took. If you cannot pinpoint a dietary cause, call your healthcare provider to rule out infection. While variations in pee color can result from ...

We list the best Gantt chart software, to make it simple and easy to better visualize and manage progress when dealing with larges projects. Gantt chart software can be a powerful weapon in a ...

Research is unclear on whether CoQ10 supplements can help your heart health or help relieve muscle pain ... and statin medications. People with certain conditions may have lower levels of a ...

In each specialty each of the physicians who were observed is represented by a separate letter. Each physician was observed on either one or two occasions. 1 Dept of Cardiology, Auckland City ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty big deal,” Gupta said. “As you just mentioned, it’s been ...

We list the best free Gantt chart software, to make it simple and easy to follow the progress of project management schedules, without a paid-for subscription. A Gantt chart is a very important ...

The use of Journavx for moderate to severe pain has not been studied beyond 14 days. The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to ...